Related Experiment Video
Updated: Jul 10, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast
Miriam Lee-Rueckert1, Riikka Vikstedt, Jari Metso
1Wihuri Research Institute, Helsinki, Finland.
Insights
Mast cells in atherosclerosis secrete chymase, which degrades cholesteryl ester transfer protein (CETP). HDL complexation protects CETP and discoidal HDL, suggesting a role for CETP in reverse cholesterol transport.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Cell Biology
Background:
- Human atherosclerotic intima contains mast cells secreting chymase.
- Intimal fluid contains HDL-modifying proteins like cholesteryl ester transfer protein (CETP) and nascent discoidal HDL particles.
Purpose of the Study:
- Investigate chymase-dependent degradation of CETP and CETP-HDL complexes.
- Determine the functional consequences of this degradation on cholesterol transport.
Main Methods:
- Incubation of isolated CETP and CETP-HDL complexes with chymase.
- Analysis of CETP cleavage patterns and cholesteryl ester transfer activity.
- Assessment of cholesterol efflux from macrophage foam cells.
Main Results:
- Chymase rapidly cleaved CETP, reducing its transfer activity.
- HDL complexation attenuated chymase-dependent CETP degradation.
- Discoidal HDL (rHDL) was protected by CETP, maintaining cholesterol efflux function.
- Spherical HDLs protected CETP from chymase inactivation.
Conclusions:
- HDL complexation modifies CETP and HDL resistance to chymase.
- Spherical HDLs protect CETP, while CETP protects discoidal HDL.
- CETP-HDL complexes may play a protective role in reverse cholesterol transport in atherosclerosis.
Abstract:
Human atherosclerotic intima contains mast cells that secrete the neutral protease chymase into the intimal fluid, which also contains HDL-modifying proteins, such as cholesteryl ester transfer protein (CETP), in addition to abundant amounts of nascent discoidal HDL particles. Here, we studied chymase-dependent degradation of a) CETP isolated from human plasma and b) CETP-HDL complexes as well as the functional consequences of such degradations. Incubation with chymase caused a rapid cleavage of CETP, yielding a specific proteolytic pattern with a concomitant reduction in its cholesteryl ester transfer activity. These chymase-dependent effects were attenuated after CETP was complexed with HDL. This attenuation was more effective when CETP was complexed with HDL(3) and HDL(2) than with discoidal reconstituted high density lipoprotein (rHDL). Conversely, rHDL, but not spherical HDLs, was protected in such CETP complexes against functional inactivation by chymase. Thus, in contrast to the complexes of CETP with spherical HDLs, the ability of the CETP-rHDL complexes to promote cholesterol efflux from macrophage foam cells remained unchanged, despite treatment with chymase. In summary, complexation of CETP and HDL modifies their resistance to proteolytic inactivation: spherical HDLs protect CETP, and CETP protects discoidal HDL. These results suggest that in inflamed atherosclerotic intima, CETP, via its complexation with HDL, has a novel protective role in early steps of reverse cholesterol transport.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Receptor-mediated Endocytosis
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Atherosclerosis III: Management

